Article
Identification of a Functional CYP2C8 Variant Allele that Alters Splicing, Reduces Protein Expression, and Increases Drug Exposure.
Clinical pharmacology and therapeutics - 1 Oct 2026
Mykkänen Anssi J H, Hirvensalo Päivi, Klein Kathrin, Kaminska Dorota, Grube Markus, Tapaninen Tuija, Kiiski Johanna I, Neuvonen Mikko, Männistö Ville T, Pihlajamäki Jussi, Tzvetkov Mladen, Schwab Matthias, Tornio Aleksi, Backman Janne T, Niemi Mikko
Abstract excerpt
This study investigated genetic determinants of the pharmacokinetics of the CYP2C8 index drugs repaglinide and gemfibrozil, and their interaction in healthy participants. Sequencing data from a study with montelukast revealed a novel functional CYP2C8 allele (rs2071426, CYP2C8*19), predicted to create an intronic splice donor site. In human liver samples, CYP2C8*19 associated with transcript-specific changes in...
Read the complete abstract on PubMedTopics
- Humans
- Cytochrome P-450 CYP2C8
